A PHASE I STUDY OF AT-101 PLUS RADIOTHERAPY AND TEMOZOLOMIDE AND AT-101 PLUS ADJUVANT TEMOZOLOMIDE FOR PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA MULTIFORME

被引：0
|
作者：
Fiveash, John
Nabors, Louis B.
Mikkelsen, Tom
Peereboom, David M.
Lesser, Glenn J.
Chowdhary, Sajeel A.
Grossman, Stuart
Ye, Xiaubu
Leopold, Lance
Rosenfeld, Myrna
机构：
来源：
NEURO-ONCOLOGY | 2009年 / 11卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
下载
收藏
页码：666 / 666
页数：1
相关论文
共 50 条
  • [11] PHASE I STUDY OF VANDETANIB WITH RADIOTHERAPY AND TEMOZOLOMIDE FOR NEWLY DIAGNOSED GLIOBLASTOMA
    Drappatz, Jan
    Norden, Andrew D.
    Wong, Eric T.
    Doherty, Lisa M.
    LaFrankie, Debra C.
    Ciampa, Abigail
    Kesari, Santosh
    Sceppa, Christine
    Gerard, Mary
    Phan, Phuong
    Schiff, David
    Batchelor, Tracy T.
    Ligon, Keith L.
    Young, Geoffrey
    Muzikansky, Alona
    Weiss, Stephanie E.
    Wen, Patrick Y.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (01): : 85 - 90
  • [12] Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
    Komotar, RJ
    Wilson, DA
    Connolly, ES
    NEUROSURGERY, 2005, 57 (01) : N7 - N8
  • [13] Safety and tolerability of asunercept plus standard radiotherapy/temozolomide in Asian patients with newly-diagnosed glioblastoma: a phase I study
    Wei, Kuo-Chen
    Hsu, Peng-Wei
    Tsai, Hong-Chieh
    Lin, Ya-Jui
    Chen, Ko-Ting
    Toh, Cheng-Hong
    Huang, Hui-Lin
    Jung, Shih-Ming
    Tseng, Chen-Kan
    Ke, Yu-Xiong
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [14] Safety and tolerability of asunercept plus standard radiotherapy/temozolomide in Asian patients with newly-diagnosed glioblastoma: a phase I study
    Kuo-Chen Wei
    Peng-Wei Hsu
    Hong-Chieh Tsai
    Ya-Jui Lin
    Ko-Ting Chen
    Cheng-Hong Toh
    Hui-Lin Huang
    Shih-Ming Jung
    Chen-Kan Tseng
    Yu-Xiong Ke
    Scientific Reports, 11
  • [15] Phase II Study of Bevacizumab Plus Temozolomide During and After Radiation Therapy for Patients With Newly Diagnosed Glioblastoma Multiforme
    Kortmann, Rolf-Dieter
    STRAHLENTHERAPIE UND ONKOLOGIE, 2011, 187 (10) : 670 - 671
  • [16] Phase I/pharmacokinetic study of enzastaurin plus temozolomide during and following radiation therapy in patients with newly diagnosed glioblastoma multiforme or gliosarcoma
    Butowski, Nicholas
    Lamborn, Kathleen
    Chang, Susan
    Page, Margaretta
    Rabbitt, Jane
    Federoff, Anne
    Parvataneni, Rupa
    Nicol, Steven
    Musib, Luna
    Liepa, Astra
    Thornton, Donald
    Prados, Michael
    MOLECULAR CANCER THERAPEUTICS, 2007, 6 (12) : 3345S - 3345S
  • [17] Phase II Study of Bevacizumab Plus Temozolomide During and After Radiation Therapy for Patients With Newly Diagnosed Glioblastoma Multiforme
    Lai, Albert
    Tran, Anh
    Nghiemphu, Phioanh L.
    Pope, Whitney B.
    Solis, Orestes E.
    Selch, Michael
    Filka, Emese
    Yong, William H.
    Mischel, Paul S.
    Liau, Linda M.
    Phuphanich, Surasak
    Black, Keith
    Peak, Scott
    Green, Richard M.
    Spier, Cynthia E.
    Kolevska, Tatjana
    Polikoff, Jonathan
    Fehrenbacher, Louis
    Elashoff, Robert
    Cloughesy, Timothy
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (02) : 142 - 148
  • [18] Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma in elderly patients
    Minniti, G.
    De Sanctis, V.
    Muni, R.
    Filippone, F.
    Bozzao, A.
    Valeriani, M.
    Osti, M. F.
    De Paula, U.
    Lanzetta, G.
    Tombolini, V.
    Enrici, R. Maurizi
    JOURNAL OF NEURO-ONCOLOGY, 2008, 88 (01) : 97 - 103
  • [19] Extended adjuvant temozolomide for treatment of newly diagnosed glioblastoma multiforme
    Urgoiti, Gloria B. Roldan
    Singh, Amitabh D.
    Easaw, Jacob C.
    JOURNAL OF NEURO-ONCOLOGY, 2012, 108 (01) : 173 - 177
  • [20] Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma in elderly patients
    G. Minniti
    V. De Sanctis
    R. Muni
    F. Filippone
    A. Bozzao
    M. Valeriani
    M. F. Osti
    U. De Paula
    G. Lanzetta
    V. Tombolini
    R. Maurizi Enrici
    Journal of Neuro-Oncology, 2008, 88 : 97 - 103
12345